|
Switzerland-Si-Si Azienda Directories
|
Azienda News:
- The Phenomenon of Clopidogrel High On-Treatment Platelet Reactivity in . . .
Clopidogrel high on-treatment platelet reactivity has a negative impact on the clinical course of stroke, worsens the early- and long-term prognoses, and increases the risk of recurrent vascular events
- The impact of coagulopathy on traumatic splenic injuries
Possible pre-injury bleeding disorders include von Willebrand disease, hemophilia, and coagulopathy due to medications, such as warfarin or clopidogrel Acute traumatic coagulopathy may also be a causative factor
- The Platelet Activity After Clopidogrel Termination (PACT) Study
“Rebound” platelet hyperreactivity after discontinuation of clopidogrel has been proposed to lead to increased thrombotic risk, including late stent thrombosis However the hypothesis that discontinuation of clopidogrel results in platelet hyperreactivity has never been rigorously tested
- Clinical significance of high on-treatment platelet reactivity in . . .
High on-treatment platelet reactivity (HPR) identified after a loading dose of clopidogrel has been reported to be associated with poor prognosis within 1 year [7,8] However, there is a paucity of data on the clinical implication of HPR at 1 year after index PCI on long-term cardiovascular outcomes
- Differential Effects of Clopidogrel With or Without Aspirin on Platelet . . .
To compare effects of clopidogrel single antiplatelet therapy (SAPT) with clopidogrel-based DAPT on hemostatic system activation we conducted a randomized clinical trial in 44 volunteers (clopidogrel (d1: 600 mg, d2-6: 150 mg) ± aspirin (100 mg))
- Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients . . .
First, platelet response to ASA and clopidogrel is comparable between chronically thrombocytopenic patients and controls and second, platelet response to ASA and clopidogrel is significantly attenuated in thrombocythemic ones
- The Phenomenon of Clopidogrel High On-Treatment Platelet . . . - PubMed
The aim of the current study is to review the latest literature data to identify the prevalance and predictors of clopidogrel high on-treatment platelet reactivity among stroke subjects and to establish the potential impact on clinical outcomes and prognosis
- Platelet Aggregation and Its Association With Stent Thrombosis and . . .
Patients (n = 2,533) included in this study underwent coronary stenting after pre-treatment with clopidogrel 600 mg Adenosine diphosphate-induced platelet aggregation was assessed using a Multiplate analyzer on blood samples obtained directly before percutaneous coronary intervention
- Abstract 5770: The Platelet Activity After Clopidogrel Termination . . .
“Rebound” platelet hyperreactivity upon discontinuation of clopidogrel has been proposed to lead to increased thrombotic risk including late stent thrombosis However the hypothesis that discontinu
|
|